Reverse hepatitis B seroconversion without immunosuppression: A case report and literature review
Hepatology Forum · 2026 · 7 (4) · 420-423
DOI: 10.14744/hf.2026.64508 ↗Kurz gefasst
Fallbericht in der Zeitschrift Hepatology Forum, 2026. Verfasst von Kai Zhu und 4 weiteren Autor:innen.
Abstract (Originalsprache)
We report a case of reverse hepatitis B seroconversion in an 88-year-old woman with previously resolved hepatitis B virus (HBV) infection and sustained virologic response to hepatitis C virus (HCV) therapy. She presented with decompensated cirrhosis and was found to have newly positive hepatitis B surface antigen, hepatitis B e-antigen, and high HBV DNA levels, despite no recent immunosuppression. Entecavir was initiated with clinical and virologic improvement. This case highlights the potential for HBV reactivation years after apparent clearance, even in the absence of immunosuppression, and underscores the need for long-term monitoring in patients with prior HBV infection.
Zitieren
APA
Zhu, K., Wu, E., Tam, B., Yoshida, E. M., & Kwan, P. (2026). Reverse hepatitis B seroconversion without immunosuppression: A case report and literature review. Hepatology Forum, 7(4), 420-423. https://doi.org/10.14744/hf.2026.64508
Vancouver
Zhu K, Wu E, Tam B, Yoshida EM, Kwan P. Reverse hepatitis B seroconversion without immunosuppression: A case report and literature review. Hepatology Forum. 2026;7(4):420-423. doi:10.14744/hf.2026.64508
BibTeX
@article{Zhu2026,
author = {Zhu, Kai and Wu, Eric and Tam, Benson and Yoshida, Eric M. and Kwan, Peter},
title = {Reverse hepatitis B seroconversion without immunosuppression: A case report and literature review},
journal = {Hepatology Forum},
year = {2026},
volume = {7},
number = {4},
pages = {420--423},
doi = {10.14744/hf.2026.64508}
}
EUVIMED